| Phase 2 | 1 | |
| Phase 3 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT05775848 | Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb… | Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I) | Active, Not Recruiting | 2026-09-09 |
| NCT07678775 | Open-Label Extension Study of BBP-418 (Ribitol) for LGMD2I/R9 | Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I) | Active, Not Recruiting | 2026-07-02 |
| Phase 2 | ||||
| NCT04800874 | Study of BBP-418 in Patients With LGMD2I | LGMD2I | Active, Not Recruiting | 2026-07-21 |